A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Effect of SRP-1005 in Subjects with Huntington’s Disease (INSIGHTT)
Principal Investigator
Dr Richard Armstrong
Contact us
Email: dendron@ouh.nhs.uk
IRAS number
1013732